A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)

Abroad (travel likely)RecruitingPHASE1

Conditions

Duchenne Muscular Dystrophy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

USA012, Little Rock, Arkansas, United States
Contact: Study coordinator (Kendra Stroud) · stroudk1@archildrens.org
USA010, Davis, California, United States
Contact: Study coordinator (Amanda Marie Figueroa Lopez) · aflopez@health.ucdavis.edu
USA009, Los Angeles, California, United States
Contact: Study coordinator (Ummi Qasim) · uqasim@mednet.ucla.edu · 310-825-3284
USA002, Palo Alto, California, United States
Contact: Study coordinator (Rabia Farooquee) · rfarooquee@stanford.edu
USA005, San Diego, California, United States
Contact: Study coordinator (Elizabeth (Ellie) Moreno) · e4moreno@health.ucsd.edu
Rare Disease Research (USA004), Atlanta, Georgia, United States
Contact: Study coordinator (Laura Sutton) · laura.sutton@rarediseaseresearch.com
USA008, Rochester, New York, United States
Study coordinator · Patty_Smith@URMC.Rochester.edu
USA006, Columbus, Ohio, United States
Contact: Study coordinator (Abigail Hanson) · Abigail.hanson2@nationwidechildrens.org
USA001, Memphis, Tennessee, United States
Contact: Study coordinator (Colin Quillivan) · colin.quillivan@stjude.org
USA015, Norfolk, Virginia, United States
Contact: Study coordinator (Erika Paradiso) · erika.paradiso@chkd.org

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy

Duchenne Muscular Dystrophy (DMD)

Abroad (travel likely)RecruitingPHASE1

Nashville, United States

Safety and Dystrophin Expression of SPOT-03 in Duchenne Muscular Dystrophy (DMD) Patients

Duchenne Muscular Dystrophy (DMD)

Abroad (travel likely)RecruitingEARLY_PHASE1

Shanghai, China

Trial of Cell Based Therapy for DMD

Duchenne Muscular Dystrophy

Abroad (travel likely)RecruitingPHASE1

Minneapolis, United States

Evaluation of the Safety, Tolerability, and Efficacy of LE051 in Patients With Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy (DMD)

Abroad (travel likely)RecruitingEARLY_PHASE1

Shanghai, China